FAQs

The platform is designed to ensure patients receive the right therapy the first time, reducing time lost to ineffective treatments, minimizing toxicity, and easing the financial burden of unnecessary care. Our team is working diligently to bring this platform to patients around the world in the near future.

Our platform is not being used to inform treatment decisions yet. If you would like to contribute to research efforts to help develop our platform, you can learn more about ongoing trials and see if you live near a participating site location here.

Decentralization empowers providers and researchers by enabling them to keep specimens on-site, test multiple therapies, and gain actionable results quickly, all while maintaining full provider control over the process.

We seek to develop the first system capable of keeping live tumor tissue viable for multiple days, allowing repeated testing and delivering unparalleled insights to guide therapy decisions.

A proof of concept for measuring therapeutic response ex vivo was demonstrated by Voabil et al. in 2021. Building on this groundbreaking work, we developed a system that keeps tissue alive consistently and reliably, paving the way for transformative advancements in cancer care.

The platform enables researchers to test novel therapies directly on live tissue, providing real-time insights into drug efficacy, tissue response, and biomarker development — all in a controlled, ex vivo environment. Learn more.

The platform is designed for placement in pathology labs, enabling providers to predict the efficacy of any standard of care therapy using only a core needle biopsy. To reserve a platform, click here.